SEC recommends Phase 1 clinical trials of Reliance’s Covid Vaccine candidate
New Delhi, August 27 The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance’s recombinant COVID-19 vaccine
Read moreNew Delhi, August 27 The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance’s recombinant COVID-19 vaccine
Read moreNew Delhi, August 25 Chief Scientist of the World Health Organisation Dr Soumya Swaminathan has said that COVID-19 in India
Read moreNew Delhi, August 25 Union Health Minister Mansukh Mandaviya on Wednesday informed that all states will be provided with over
Read moreNew Delhi, August 20 Zydus Cadila has received approval for Emergency Use Authorization from the Drug Controller General of India
Read moreNew Delhi, August 11 More than 52 crore COVID vaccine doses have been administered in the country so far under
Read moreNew Delhi, August 09 The Ministry of Health and Family Welfare on Monday allowed the foreign nationals residing in India
Read moreNew Delhi, August 06 Union Health Ministry said, more than 49 crore 53 lakh COVID vaccine doses have been administered
Read moreNew Delhi, August 05 Amid the reports of delayed production of its COVID-19 vaccine due to unsatisfactory test batch and
Read moreNew Delhi, August 02 The US-based pharmaceutical company Johnson and Johnson is still in talks with the Centre over its
Read moreNew Delhi, July 31 The Centre on Saturday reviewed the Covid-19 situation in ten states that are witnessing an upsurge
Read more